Misplaced Pages

Abortion–breast cancer hypothesis

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by Phyesalis (talk | contribs) at 06:22, 21 November 2007 (added v to 'advocates'). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 06:22, 21 November 2007 by Phyesalis (talk | contribs) (added v to 'advocates')(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Template:Totally-disputed

Abortion
Main topics
Movements
Issues
By country
Africa
Asia
Europe
North America
Oceania
South America
Law
Methods
Religion

The abortion-breast cancer (ABC) hypothesis (also referred to by supporters as the abortion-breast cancer link) posits a causal relationship between induced abortion and an increased risk of developing breast cancer. In early pregnancy, levels of estrogen increase, leading to breast growth in preparation for lactation. The hypothesis proposes that if this process is interrupted by an abortion – before full maturity in the third trimester – then more relatively vulnerable immature cells could be left than there were prior to the pregnancy, resulting in a greater potential risk of breast cancer. While early research suggested the possibility of a correlative relationship between breast cancer and abortion, the causal hypothesis was proposed based on a reinterpretation of rat studies conducted in the 1980s. Though the hypothesis has been rejected by the scientific community and abortion is not considered a breast cancer risk by any major cancer organization, it continues to be championed by pro-life activists like Dr. Joel Brind, Dr. Angela Lanfranchi and Dr. Karen Malec.

The ongoing prominence of the abortion-breast cancer hypothesis, despite the lack of clear scientific evidence, is seen by some as a part of the current pro-life "women-centered" strategy against abortion. Pro-life advocates sought legal action regarding disclosure of possible risks. While the suits brought short term political intervention, the NCI responded by forming a consensus workshop in 2003 that determined with a rating of 1 (well-established) that there was no link between abortion and breast cancer. This determination has been upheld by the scientific community at large. The current scientific consensus that abortion does not increase the risk of breast cancer has solidified with the publication of large prospective cohort studies which find no significant association between abortion and breast cancer. Nevertheless, the subject continues to be one of mostly political but some some scientific debate.

Proposed mechanism

While research has shown the protective benefits of pregnancy and lactation in reducing the risk of breast cancer, the abortion-breast cancer hypothesis reinterprets this benefit as having a correlative adverse effect for those women who have had abortions. Dr. Brind argues that abortion increases a woman's potential risk of breast cancer by creating and leaving behind more immature cells to be exposed to carcinogens and hormones over time.

Breast tissue contains many lobes (segments) and these contain lobules which are groups of breast cells. There are four types of lobules:

  • Type 1 has 11 ductules (immature)
  • Type 2 has 47 ductules (immature)
  • Type 3 has 80 ductules (mature, fewer hormone receptors)
  • Type 4 lobules are fully matured (cancer resistant) and contain breast milk

During early pregnancy type 1 lobules quickly become type 2 lobules because of changes in estrogen and progesterone levels. Maturing into type 3 and then reaching full differentiation as type 4 lobules requires an increase of human placental lactogen (hPL) which occurs in the last few months of pregnancy. According to the abortion-breast cancer hypothesis, if an abortion were to interrupt this sequence then it could leave a higher ratio of type 2 lobules than existed prior to the pregnancy. Russo and Russo have shown that mature breast cells have more time for DNA repair with longer cell cycles which would account for the reduced risk of parturition against the baseline risk for women who have never conceived and those who have conceived and terminated their pregnancies.

Later on Russo et al. found that placental human chorionic gonadotropin (hCG) induces the synthesis of inhibin by the mammary epithelium. Bernstein et al. independently observed a reduced breast cancer risk when women were injected with hCG for weight loss or infertility treatment. Michaels et al. hypothesize since hCG plays a role in cellular differentiation and may activate apoptosis, as levels of hCG increase early on in human pregnancy, "an incomplete pregnancy of short duration might impart the benefits of a full-term pregnancy and thus reduce the risk of breast cancer."

NCI workshop

The National Cancer Institute (NCI) conducted a workshop to evaluate the scientific evidence regarding the abortion-breast cancer hypothesis. This was done in response to alterations to the NCI website by the Bush administration in November 2002, which prompted an editorial in the New York Times and members of Congress writing a letter to the Secretary of Health and Human Services. The workshop concluded that the evidence was well-established that abortion did not increase a woman's risk of breast cancer.

Dr. Joel Brind, a pro-life activist, and the primary advocate of an abortion-breast cancer link and an invitee to the workshop, filed a dissenting opinion criticizing the NCI's and Melbye's conclusions. Brind alleges the workshop evidence and findings were overly controlled by its organizers since Dr. Daling, who has published on the abortion-breast cancer issue, was asked to present on another topic; and preterm delivery was listed as an epidemiological "gap" (no evidence available) even though there was preliminary evidence of a correlation with higher breast cancer risk.

Scientific studies

Background

The first study with abortion-breast cancer results was in 1957, which was a broad study examining all common cancers in Japan. The researchers were cautious about drawing any conclusions from their unreliable methodologies. During the 1960s several studies by Brian MacMahon et al. in Europe and Asia touched on a correlation between abortion and breast cancer. Their results were summarized by the Journal of the National Cancer Institute in 1973 which inaccurately concluded that "where a relationship was observed, abortion was associated with increased, not decreased, risk." Research relevant to the current ABC discussion focuses on more recent large cohort studies, a few meta-analyses, many case-control studies and several early experiments with rats.

Rats

Drs. Russo & Russo from the Fox Chase Cancer Center in Philadelphia conducted a study in 1980 which examined the proposed correlation between abortion and breast cancer. Russo and Russo examined the effects of the carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) on the DNA labeling index (DNA-LI) in terminal end buds (TEBs), terminal ducts (TDs) and alveolar buds (ABs) of Sprague-Dawley rats in various stages of reproductive development. Russo and Russo found that rats who had interrupted pregnancies had no noticable increase in risk for cancer. However, they did find that pregnancy and lactation provided a protective measure against various forms of benign lesions, like hyperplastic alveolar nodules and cysts. While results did suggest that rats who had interrupted pregnancies might be subject to "similar or even higher incidence of benign lesions" than virgin rats, there was no evidence to suggest that abortion would result in a higher incidence of carcinogenesis. A more thorough examination of the phenomenon was conducted in 1982, which confirmed the results. A later study in 1987 further explained their previous findings. After differentiation of the mammary gland resulting from a full-term pregnancy of the rat, the rate of cell division decreases and the cell cycle length increases, allowing more time for DNA repair.

Despite the fact that the Russos' study found no increase in risk associated with abortion, their research would be used to support the contention that abortion created a greater risk of breast cancer for the next twenty years. In a Discover article sidebar entitled Humans Are Not Rats, Dr. Gil Mor, the director of reproductive immunology at the Yale University School of Medicine, disagrees with Dr. Brind on the importance of the rat studies findings. Dr. Mor emphasizes that rat studies are ideal for understanding basic processes but because rats have neither breasts nor breast cancer, people like Dr. Brind are on "wobbly" terrain.

Confounding factors and hormones

There are many confounding factors for breast cancer. Genetics is a major factor that affects not only a woman's initial breast cancer risk but also her hormonal sensitivity, which in turn affects her susceptibility to a long list of socioeconomic and environmental factors. As Western society has modernized environmental carcinogens, delayed child rearing, less breastfeeding, hormone replacement therapy (HRT), hormonal contraception, early menarche and obesity have increased.

If unaccounted for these factors could obscure any individual variable. Scientific studies remove them using case-control methodology – a woman who has had an abortion (case) is matched with a very similar woman with no abortion history (control) – if this was not done a study could get a false positive or negative result because of another factor. Examining the ABC issue is all the more difficult because the number of women with an induced abortion history has increased along with other factors in recent decades. Premature birth adds further complications since uncorroborated studies have indicated it is associated with a history of induced abortion and higher breast cancer risk. One of the most significant controllable factors for breast cancer is parity, or the number of children a women has given birth to. With each full-term pregnancy (particularly the first) the breasts undergo growth and differentiation (in the third trimester); consequently, having no children can increase breast cancer risk.

All of these confounding factors have an effect, directly or indirectly, on hormones which impact breast cancer risk, but they do not significantly affect the results of ABC studies that are properly conducted and take these factors into account with case-control matching. Hormones being a key factor for cancer risk is well established. Steroidal estrogen was added to the federal carcinogen list in December 2002. The American Cancer Society (ACS) and the National Cancer Institute (NCI) note reproductive hormones can elevate breast cancer risk. In particular a Women's Health Initiative hormone replacement therapy study was cut short from an elevated breast cancer and heart risk using estrogen with progestin.

The controversial nature of abortion may introduce response bias into interview studies, especially for studies done in decades past when abortion was less accepted. In the late 20th century there was some concern of an increase of breast cancer incidence. This was found to be partly due to women living longer, and that better detection methods were finding breast cancer earlier.

Cohorts

The majority of the results in epidemiology are calculated as a relative risk. For example 1.0 (0.95 - 1.04) is no change in risk, whereas 1.51 is a 51% increased risk and 0.7 is a 30% decreased risk. It is followed by a 95% confidence interval in brackets that shows the actual risk has a 95% chance of being within the range given, so that (0.95 - 1.04) is the margin of error and there is a potential range of 5% decreased or a 4% increased risk. With more data the confidence interval becomes smaller; making it an indicator of the result's statistical reliability. The number of (X/Y breast cancer cases/controls) gives X as women in the study who have had induced abortion(s) and Y is women with no abortion and miscarriage history. This provides an indication of the size of the actual data set being used to calculate the relative risk in relation to induced abortion.

Howe

The 1989 study by Holly Howe et al. at the New York State Department of Health examined young women with breast cancer in upstate New York (1,451 breast cancer cases/controls). The results indicated a significant 1.9 (1.2 - 3.0) increased risk for induced abortion and an insignificant 1.5 (0.7 - 3.7) increase for spontaneous abortion. The authors believed that the study was inconclusive, but raised new questions for continuing research as women's recorded contraceptive histories grew.

Dr. Newcomb and Michels pointed out it examined only very young women and did not account for some confounding factors such as family history of breast cancer. Scott Somerville of the conservative group Accuracy in Media claims that it took a long time for Howe's study to be published due to a number of American journals that rejected the article. The Howe study was published in the Britain-based International Journal of Epidemiology in 1989.

Melbye

A large, highly regarded ABC study was published by Melbye et al. (1997) of the Statens Serum Institute in Copenhagen, which had 1.5 million Danish women in the study's database (1,338/8,908 breast cancer cases/controls). Of those women, 280,965 of them had induced abortions recorded in the computerized registry, which was started in 1973 when having an induced abortion through 12 weeks was fully legalized in Denmark. The relative risk after statistical adjustment came to 1.00 (0.94 - 1.06); meaning there was zero percent increase or decrease in breast cancer risk. This led to the conclusion that "induced abortions have no overall effect on the risk of breast cancer." The Melbye study's conclusions garnered great attention from the media and many organizations, such as the NCI and Planned Parenthood, who use it as a foundation to argue that the best scientific evidence does not support an ABC link.

The Melbye study used women born from 1935 to 1978, but the computerized registry of induced abortions only started in 1973. Drs. Brind and Chinchilli had concerns about the Melbye study database and how they statistically adjusted their overall relative risk. Dr. Melbye et al. responded that if the misclassified older women had their risk underestimated, it would be expected that the younger groups would have a higher risk. Their statistically adjusted relative risks indicated this was not the case. Dr. Brind argues that Dr. Melbye et al. adjusted out induced abortion from the overall results as they collectively removed confounding factors that increased over time (eg. smoking, late child bearing, obesity, etc.) and finding no ABC risk was a consequence and a red flag. Dr. Melbye et al. found the point to be self-contradictory, considering Dr. Brind wanted birth-cohort matching, then argued against "taking birth-cohort differences into account." Dr. Brind clarifies he is against the use of just statistical adjustment and that standard case-control matching may more accurately account for birth-cohort differences.

Another letter to the editor from Drs. Senghas and Dolan questioned why a statistically significant result for induced abortions done after 18 weeks gestation was not specifically addressed in the results section of the Melbye study abstract. Melbye et al. explained that even though the result was "in line with the hypothesis of Russo and Russo," they deemed the number of cancer cases small and did not want to overstate the finding. The first section of Table 1 in the Melbye study:

Week of gestation No. of Cancers Person-Years Relative Risk (95% CI) * Multivariate Relative Risk (95% CI) †
<7 36 82 000 0.81 (0.58-1.13) 0.81 (0.58-1.13)
7-8 526 1 012 000 1.01 (0.89-1.14) 1.01 (0.89-1.14)
9-10‡ 534 1 118 000 1 1
11-12 205 422 000 1.12 (0.95-1.31) 1.12 (0.95-1.31)
13-14 6 14 000 1.13 (0.50-2.52) 1.13 (0.51-2.53)
15-18 17 35 000 1.24 (0.76-2.01) 1.23 (0.76-2.00)
>18 14 14 000 1.92 (1.13-3.26) 1.89 (1.11-3.22)

* The relative risks were calculated separately for each of the five variables, with adjustment for women's age, calendar period, parity, and age at delivery of a first child. CI denotes confidence interval.
† Values were adjusted for women's age, calendar period, parity, age at delivery of a first child, and the other variables shown in the table.
‡ The women with this characteristic served as the reference group.

Other sections listed age at induced abortion, number of induced abortions, time since induced abortion, and time of induced abortion and live-birth history. There was an indication of an elevated risk of 1.29 (0.80-2.08) for 12-19 year olds (relative to 20-24 subcohort), and a protective effect 0.74 (0.41-1.33) for women with an induced abortion before and after their first live birth (relative to induced abortion after 1st live birth subcohort).

Michels

A study by Michels et al. (2007) from the Harvard School of Public Health containing 105,716 women (233/1,225 breast cancer cases/controls) concluded with a relative risk of 1.01 (0.88 - 1.17) "after adjustment for established breast cancer risk factors." Some of the results lead the study to stipulate: "Although our data are not compatible with any substantial overall relation between induced abortion and breast cancer, we cannot exclude a modest association in subgroups defined by known breast cancer risk factors, timing of abortion, or parity." The following are induced abortion results from Table 4 of the Michels study, with parity distinguished between nulliparous (no children) and parous (had children):

Parity* No. of Breast Cancer Cases† No. of Person-Years Age-Adjusted HR (95% CI) Covariate-Adjusted HR (95% CI)‡ P Value for the Test of Heterogeneity
Nulliparous
 No induced abortion 243§ 159 290 1 1
  Abortion
   ER+ 42 34 862 1.27 (0.90-1.79) 1.25 (0.87-1.78) .65
   ER− 14 34 884 1.45 (0.79-2.68) 1.35 (0.71-2.58)
   PR+ 33 34 865 1.49 (1.00-2.22) 1.39 (0.92-2.11) .73
   PR− 12 34 889 1.25 (0.65-2.40) 0.97 (0.49-1.93)
Parous
 No induced abortion 962|| 642 741 1 1
  Abortion
   ER+ 99 112 347 0.99 (0.80-1.23) 0.95 (0.77-1.18) .40
   ER− 35 112 405 1.17 (0.81-1.69) 1.20 (0.83-1.74)
   PR+ 59 112 382 0.84 (0.64-1.11) 0.80 (0.60-1.05) .002
   PR− 47 112 393 1.62 (1.17-2.23) 1.58 (1.13-2.20)

Abbreviations: CI, confidence interval; ER+, estrogen receptor positive; ER−, estrogen receptor negative; HR, hazard ratio; PR+, progesterone receptor positive; PR−, progesterone receptor negative.

* Parity status was updated in the regression analysis at every 2-year interval. The number of women who were nulliparous and reported spontaneous abortions was too small to calculate reasonably stable estimates.

† Cases with ER information and cases with PR information may overlap.

‡ The HRs and 95% CIs among nulliparous women were adjusted for age, birth weight, premature birth, family history of breast cancer, history of benign breast disease, height, body mass index at the age of 18 years and current body mass index (calculated as weight in kilograms divided by height in meters squared), age at menarche, oral contraceptive use, alcohol consumption, physical activity, menopausal status, age at menopause, and postmenopausal hormone use. The HRs and 95% CIs among parous women were adjusted for the same covariates as the HRs and 95% CIs among nulliparous women and in addition for parity and age at first birth.

§ Total number of cases, including 149 ER+ and 42 ER− (a total of 191 cases with known ER status), and 99 PR+ and 41 PR− (a total of 140 cases with known PR status) cases. The incidence of breast cancer with corresponding ER/PR status was used when calculating HRs of ER+, ER−, PR+, and PR− breast cancer.

|| Total number of cases, including 586 ER+ and 174 ER− (a total of 760 cases with known ER status), and 413 PR+ and 172 PR− (a total of 585 cases with known PR status) cases. The incidence of breast cancer with corresponding ER/PR status was used when calculating HRs of ER+, ER−, PR+, and PR− breast cancer.

Further cohort studies

Several more recent prospective cohort studies have also found little evidence of a link between induced abortion and breast cancer. A study of 267,361 European women (746/2,908 breast cancer cases/controls), published in 2006, found no significant ABC risk. Another 2006 study involving 267,400 women (872/771 breast cancer cases/controls) in Shanghai found no evidence of an ABC link. In fact, this study noted that women who had an abortion were at a significantly decreased risk of uterine cancer.

Another cohort study by Lindefors-Harris et al. (1989) was done looking at 49,000 women who had received abortions before the age of 30 in Sweden (65 breast cancer cases – compared with estimate of occurrence in general population). Although reported by some sources as being a "large" cohort study the actual number of breast cancer cases is a fraction of most other studies. The risk for women who'd given birth previous to the abortion was 0.58 (0.38 - 0.84), whereas women with no births had an insignificant risk increase of 1.09 (0.71 - 1.56). Overall, the relative risk was 0.77 (0.58 - 0.99), making for a 23% reduced risk in comparison to "contemporary Swedish population with due consideration to age." The conservative political group Accuracy in Media (AIM) criticized the Lindefors-Harris study, claiming that the Lindefors-Harris control group was not well-defined and did not account for differences between how Swedish and American women use abortion. AIM also alleged bias in the study because funding came from Family Health International, a large pro-choice non-profit organization trying to meet the public health needs of the world's poorest people.

Meta-analysis

Beral

In March 2004, Dr. Beral et al. published a study in The Lancet as a collaborative reanalysis on Breast cancer and abortion. This meta-analysis of 53 epidemiologic studies of 83,000 women with breast cancer undertaken in 16 countries did not find evidence of a relationship between induced abortion and breast cancer, with a relative risk of 0.93 (0.89 - 0.96). Dr. Brind maintains this study is a meta-analysis rather than a "collaborative reanalysis" and like other meta-analyses is subject to selection bias. He also criticizes that Lindefors-Harris conceded in 1998 their initial response bias conclusion may have been unsound, but this was not noted by the Beral study which used Lindefors-Harris to support a response bias hypothesis to account for higher ABC risk found in interview based studies. Many organizations and media outlets have referenced the Beral study as the most comprehensive overview of the ABC evidence.

Brind

A meta-analysis was conducted by Dr. Brind et al. (1996) with both pro-choice and pro-life scientists that examined 28 published studies. It concluded that there was on average a 1.3 (1.2 - 1.4) increased risk of breast cancer. The meta-analysis was criticized for selection bias by using studies with widely varying results, not working with the raw data from several studies, and including some studies that have alleged methodological weaknesses. The Royal College of Obstetricians and Gynaecologists in March 2000 published evidence-based guidelines on women requesting induced abortion. The review of the available evidence at the time was "inconclusive" regarding the ABC link. They also noted "Brind's paper had no methodological shortcomings and could not be disregarded."

Interviews

Interview (case-control) based studies have been inconsistent on the ABC link. With the small numbers involved in each individual study and the possibility that recall bias skewed the results, recent focus has switched to meta-analysis and record based studies which are typically much larger. Here are a few interview studies of note.

Daling

Dr. Daling from the Fred Hutchinson Cancer Research Center headed two studies on the ABC issue looking at women in Washington state. The 1994 study (845/961 breast cancer cases/controls) results indicated a 1.5 (1.2 - 1.9) increased risk. This was reflected in higher risks for women younger than 18 or older than 30 years of age who have had abortions after 8 weeks' gestation. Their conclusion emphasized that although this study supported the ABC link, the overall results from epidemiologic studies are inconsistent.

The Daling study in 1996 (1,302/1,180 breast cancer cases/controls) resulted in a relative risk of 1.2 (1.0 - 1.5). The risk was highest among women without children who had abortions prior to 9 weeks gestation. Dr. Daling et al. examined the possibility of response bias by comparing results from two recent studies on invasive cervical cancer and ovarian cancer. The results argued against significant response bias. The Rookus (1996) study noted that patients with cervical cancer may report differently than breast cancer patients.

Sanderson

A 2001 study (1,459/1,556 breast cancer cases/controls) conducted in Shanghai, China by Dr. Sanderson from the University of South Carolina and South Carolina Cancer Center at Columbia concluded that there was no ABC link and that multiple abortions did not put one at greater risk. Since induced abortion is common, legal, and even mandated by the government in China, the recall bias was minimized.

Critics of the Chinese studies have said that the same factors that make them ideal for reducing recall bias also makes them inappropriate for comparison to the West. With the wide availability of abortion services, over 80% of them were done within the first eight weeks of gestation. In comparison only 55% of American women had an abortion before the ninth week. Due to China’s strict population control, the vast majority of the abortions in the Chinese study were done after the first full-term pregnancy, which had been relatively early. This is not reflected in North America.

Response bias

Response bias for ABC normally occurs when women intentionally "underreport" their abortion history, meaning that they deny having an abortion or claim to have fewer abortions than they actually had. This can happen because of the personal, and in some places controversial, nature of abortion, which may cause some women to not want to provide full disclosure. Women in the control group are more likely to have no serious illnesses, and hence have less motivation to be truthful than those trying to diagnose their problem. If this occurred then it would artificially create an ABC link where none existed. Two major studies have been published examining abortion response bias.

A review of ABC studies was conducted by Dr. Bartholomew in 1998. It concluded that if studies least susceptible to response bias are considered, they suggest there is no ABC link. However, some political foes of abortion point out there is no "plausible evidence of report bias" for those interview based studies. An editorial in the Journal of the National Cancer Institute examined the notion of epidemiology reaching its limit given the possibility of response bias putting results in doubt. It concluded:

Indeed, after this excursion into the issue of abortion, bias, and breast cancer, it seems our future has as much to do with human behavior as with human biology.

Lindefors-Harris

The Lindefors-Harris (1991) study (317/512 breast cancer cases/controls) was the first major study to examine response and recall bias. It used the data of two independent Swedish induced abortion studies, and concluded there was a 1.5 (1.1 - 2.1) margin of error due to recall bias. However, eight women (seven cases, one control) included in this error margin apparently "overreported" their abortions, meaning the women reported having an abortion that was not reflected in the records. It was decided that for the purposes of the study, these women did not have abortions.

Dr. Daling (1994) found it "reasonable to assume that virtually no women who truly did not have an abortion would claim to have had one," and missing records could have occurred for a variety of reasons. With these eight women removed the error margin is reduced from 50% to 16% which severely limits its statistical significance. Dr. Brind believes the remaining 16% could have resulted from the Swedish fertility registry – where women were interviewed as mothers – which could have increased their tendency to underreport, given that a mother might not want to appear unfit. Subsequently the Lindefors-Harris obliquely retracted the 50% conclusion in 1998, but reasserted since the Denmark (Melbye 1997) cohort study found no ABC correlation the 30% increased risk in the Brind meta-analysis must be the accumulative result of response bias.

Rookus

The Rookus (1996) study (918 breast cancer cases/controls) compared two regions in the Netherlands to assess the effect of religion on ABC results based on interviews. The secular (western) and conservative (southeastern) regions showed ABC relative risks of 1.3 (0.7 - 2.6) and 14.6 (1.8 - 120.0) respectively. Although this was a large variance, Dr. Brind et al. pointed out that it was attained with an extremely small sample size. (12 cases and 1 control)

Rookus et al. supported this finding with an analysis of how much recall bias existed with oral contraceptive use that could be verified through records. It corroborated the bias, but Brind's et al. letter clarifies it only indicated response bias between the two regions, not between case and control subjects within regions. Dr. Rookus et al. responded to the criticism by noting that there was 4.5 month underreporting difference between control and case subjects in the conservative region. This is indirect evidence for reporting bias since comfort with reporting oral contraception should be higher than induced abortion. Rookus et al. also acknowledged the weakness in the Lindefors-Harris (1991) study, but emphasized that more controls (16/59 = 27.1%) than case patients (5/24 = 20.8%) did not report registered induced abortions. They concluded that finding a causal ABC link would be a disservice to the public and to epidemiologic research if "bias has not been ruled out convincingly."

Spontaneous abortion

Studies of spontaneous abortions (miscarriages) have generally shown no increase in breast cancer risk, although a study by Dr. Paoletti concluded there is a "suggestion of increased risk" 1.2 (0.92 - 1.56) after 3 or more pregnancy losses. Some argue that this apparent lack of effect of miscarriages on breast cancer risk is evidence against the ABC hypothesis, and some pro-choice advocates have claimed it is proof that neither early pregnancy loss nor abortion are risk factors for breast cancer.

One of the problems with comparing miscarriage to abortion is the issue of hormone levels in early pregnancy, a key point because the ABC hypothesis rests on hormonal influence over breast tissue development. While it is true most miscarriages are not caused by low hormones, most miscarriages are characterized by low hormone levels. Kunz & Keller (1976) showed that when progesterone is abnormally low a miscarriage occurs 89% of the time. Advocates of an ABC link argue that, given the association of most miscarriages with abnormally low hormone levels, spontaneous abortion is not analogous to an induced abortion.

A distinction should also be made for second trimester miscarriages as their hormonal characteristics differ from first trimester miscarriages.

Politicization

Pro-life organizations lobby to increase obstacles to abortion, such as mandated counseling, waiting periods, and parental notification, and some feel that pro-life advocates treat ABC as simply another tactic in their campaign against abortion. There has been ongoing and incremental legal challenges to abortion in the United States by pro-life groups. In 2005, a Canadian pro-life organization put up billboards in Alberta with large pink ribbons and the statement: "Stop the Cover-Up," in reference to the abortion-breast cancer hypothesis. The Canadian Breast Cancer Foundation was concerned the billboards misrepresented the state of scientific knowledge on the subject.

The continued focus on the "ABC link" by pro-life groups has led to a backlash by pro-choice advocates, which has created a confrontational political environment at the expense of science. As a result, the ABC hypothesis is incorrectly referred to as pseudoscience by a few pro-choice organizations. Studies are dismissed if their results contradict the current consensus of no ABC association, but others that refute the ABC hypothesis are supported uncritically.

During the late 1990s several United States congressman became involved in the ABC issue. In 1998, congressman Tom Coburn questioned a National Cancer Institute (NCI) official on why the NCI website contained out of date information on the ABC issue. Congressman Dave Weldon wrote a "Dear Colleague" letter to congress in 1999 shortly after the House debated FDA approval of the abortion drug Mifepristone; and partially as a result of John Kindley's law review on informed consent which was enclosed. In it Weldon expressed concern over studies indicating an ABC link and the politicization of the ABC issue "preventing vital information from being given to women." Congressman Tom Bliley led an investigation into the representation of the ABC issue by the NCI, resulting in the NCI updating their website.

As of 2004 state law in Minnesota, Mississippi, Texas, Louisiana, and Kansas requires warning women seeking abortions about a possible breast cancer risk. Similar legislation requiring notification has also been introduced, and was pending, in 14 other states. An editor for the American Journal of Public Health expressed concern over how such legislative bills propose warnings that do not agree with established scientific findings. However, it is possible that such legally-mandated disclosure could mitigate possible future lawsuits involving informed consent from women who might contend they should have been told of the ABC link possibility prior to having an abortion.

North Dakota lawsuit

In January of 2000 Amy Jo Kjolsrud (née Mattson), a pro-life counselor, sued the Red River Women's Clinic in Fargo, North Dakota alleging false advertising. The suit alleged the clinic was misleading women by distributing a brochure quoting a National Cancer Institute fact sheet on the ABC issue which stated:

"Anti-abortion activists claim that having an abortion increases the risk of developing breast cancer and endangers future childbearing. None of these claims are supported by medical research or established medical organizations." (emphasis in original)

The case was originally scheduled for September 11, 2001, but was delayed as a result of the terrorist attacks. On March 25, 2002, the trial started and after four days of testimony Judge Michael McGuire ruled in favor of the clinic. In his decision he said:

It does appear that the clinic had the intent to put out correct information and that their information is not untrue or misleading in any way. They did exercise reasonable care... One thing is clear from the experts, and that is that there are inconsistencies. The issue seems to be in a state of flux.

The judge noted it was their "intent" to provide accurate information because the brochure used an outdated 1996 fact sheet that stated there was "no established link", instead of the 1999 fact sheet wording of "inconsistent" evidence for the ABC issue. Linda Rosenthal, an attorney from the Center for Reproductive Rights characterized the decision thusly: "The judge rejected the abortion-breast cancer scare tactic. This ruling should put to rest the unethical, anti-choice scare tactic of using pseudo-science to harass abortion clinics and scare women." John Kindley, one of the lawyers representing Ms. Kjolsrud stated: "I think most citizens, whether they are pro-choice or pro-life, believe in an individual's right to self-determination. They believe people shouldn't be misled and should be told about risks, even if there is controversy over those risks." Kindley also wrote an article published in 1998 by the Wisconsin Law Review outlining the viability of medical malpractice lawsuits based upon not informing patients considering abortion about the evidence indicating an ABC link.

The decision was appealed and on September 23, 2003, to the North Dakota Supreme Court which ruled the false advertising law should not have been used by Ms. Kjolsrud. This was because she personally had suffered no injury and hence had no standing (according to North Dakota jurisprudence) to file the lawsuit on behalf of others. In the appeal, Ms. Kjolsrud "concedes she had not read the brochures before filing her action." However, the appeal also noted that after the lawsuit was filed the abortion clinic updated their brochure to the following:

"Some anti-abortion activists claim that having an abortion increases the risk of developing breast cancer. A substantial body of medical research indicates that there is no established link between abortion and breast cancer. In fact, the National Cancer Institute has stated, 'here is no evidence of a direct relationship between breast cancer and either induced or spontaneous abortion.'"

Patrick Carroll

Patrick S. Carroll published a statistical analysis in the Journal of American Physicians and Surgeons, a politically conservative and controversial journal with an explicit pro-life stance. It forecasts, for the year 2025, higher breast cancer rates for Czech Republic, England and Sweden and lower for Finland and Denmark based on abortion trends. Carroll's study was criticized by The Guardian, which argued that the study's methodology was flawed and noted that it was funded by an anti-abortion group and published in a "rightwing" journal.

References

  1. ^ "Reproductive Breast Cancer Risks Brochure". Retrieved 2007-10-20.
  2. ^ Russo J, Russo I (1980). "Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence". Am J Pathol. 100 (2): 497–512. PMID 6773421.
  3. ^ Russo J, Tay L, Russo I (1982). "Differentiation of the mammary gland and susceptibility to carcinogenesis". Breast Cancer Res Treat. 2 (1): 5–73. PMID 6216933.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ^ Russo J, Russo I (1987). "Biological and molecular bases of mammary carcinogenesis". Lab Invest. 57 (2): 112–37. PMID 3302534.
  5. ^ "Planned Parenthood - Anti-Choice Claims About Abortion and Breast Cancer". plannedparenthood.org. Retrieved 2007-11-04.
  6. ^ "THE PRO-CHOICE ACTION NETWORK". prochoiceactionnetwork-canada.org. Retrieved 2007-11-04.
  7. ""Research and Destroy" by Chris Mooney". Retrieved 2007-10-01.
  8. ^ "ACS :: What Are the Risk Factors for Breast Cancer?". cancer.org. Retrieved 2007-11-04.
  9. ^ Michels KB, Xue F, Colditz GA, Willett WC (2007). "Induced and spontaneous abortion and incidence of breast cancer among young women: a prospective cohort study". Arch. Intern. Med. 167 (8): 814–20. doi:10.1001/archinte.167.8.814. PMID 17452545.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  10. ^ Jasen P (2005). "Breast cancer and the politics of abortion in the United States". Med Hist. 49 (4): 423–44. PMID 16562329.
  11. ^ Howe H, Senie R, Bzduch H, Herzfeld P (1989). "Early abortion and breast cancer risk among women under age 40". Int J Epidemiol. 18 (2): 300–4. PMID 2767842.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  12. ^ "Adolescent Diet & Risk of Bca". annieappleseedproject.org. Retrieved 2007-11-04.
  13. Alvarado MV, Alvarado NE, Russo J, Russo IH (1994). "Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human breast epithelial cells in vitro". In Vitro Cell. Dev. Biol. Anim. 30A (1): 4–8. PMID 8193772.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  14. Russo IH, Koszalka M, Russo J (1990). "Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis". Carcinogenesis. 11 (10): 1849–55. PMID 2119909.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  15. Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK (1995). "Treatment with human chorionic gonadotropin and risk of breast cancer". Cancer Epidemiol. Biomarkers Prev. 4 (5): 437–40. PMID 7549796.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  16. ^ "Politics & Science - Investigating the State of Science Under the Bush Administration". Retrieved 2007-11-04.
  17. Cite error: The named reference NCI was invoked but never defined (see the help page).
  18. "Breast Cancer Prevention Institute". bcpinstitute.org. Retrieved 2007-11-04.
  19. "Minority Dissenting Comment - National Cancer Institute". Retrieved 2007-11-04.
  20. ^ Melbye M, Wohlfahrt J, Andersen AM, Westergaard T, Andersen PK (1999). "Preterm delivery and risk of breast cancer". Br. J. Cancer. 80 (3–4): 609–13. doi:10.1038/sj.bjc.6690399. PMID 10408874.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  21. B MacMahon, P Cole, and J Brown (1973). "Etiology of human breast cancer: a review". J. Nat. Cancer Inst. 50 (21–42): 22. PMID 4571238.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  22. Jasen, Patricia (2005). "Breast Cancer and the Politics of Abortion in the United States". Medical History. 49 (4): 423–444. Retrieved 2007-11-16. "Over the next two decades, however, their findings would be cited repeatedly as evidence that pregnancy begins a process of breast change which, when stopped by abortion, put female rats (and thus humans) at greater risk of cancer than those who had never been pregnant. {{cite journal}}: Cite has empty unknown parameter: |coauthors= (help); Unknown parameter |month= ignored (help)
  23. "Scientist Who Hated Abortion". Discover. Retrieved 2007-11-04.
  24. "Cancer Risk and Abnormal Breast Cancer Genes". Retrieved 2007-11-04.
  25. ^ "Facts on Induced Abortion in the United States". guttmacher.org. Retrieved 2007-11-04.
  26. Moreau C, Kaminski M, Ancel PY; et al. (2005). "Previous induced abortions and the risk of very preterm delivery: results of the EPIPAGE study". BJOG : an international journal of obstetrics and gynaecology. 112 (4): 430–7. doi:10.1111/j.1471-0528.2004.00478.x. PMID 15777440. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  27. "Breast Cancer Facts & Figures 2001-2002" (PDF). Retrieved 2007-11-04.
  28. "Estrogen Receptors/SERMs - National Cancer Institute". Retrieved 2007-11-04.
  29. "New Federal Report On Carcinogens Lists Estrogen Therapy, Ultraviolet, Wood Dust". Retrieved 2007-11-04.
  30. "JAMA -- Abstract: Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial, June 25, 2003, Chlebowski et al. 289 (24): 3243". Retrieved 2007-11-04.
  31. Weed DL, Kramer BS (1996). "Induced abortion, bias, and breast cancer: why epidemiology hasn't reached its limit". J. Natl. Cancer Inst. 88 (23): 1698–700. PMID 8943995.
  32. Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T (1993). "The lifetime risk of developing breast cancer". J. Natl. Cancer Inst. 85 (11): 892–7. PMID 8492317.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  33. "Judge to Rule on Abortion, Breast Cancer Link". womensenews.org. Retrieved 2007-11-04.
  34. ^ "Before you choose abortion". Steve Frezza. Retrieved 2007-11-04.
  35. ^ Cite error: The named reference MELBYE was invoked but never defined (see the help page).
  36. ^ Brind J, Chinchilli VM (1997). "Induced abortion and the risk of breast cancer". N. Engl. J. Med. 336 (25): 1834, author reply 1835. PMID 9190496.
  37. "ABC in the courts: Dramatic ABC testimony in Florida's parental notification appeal". Retrieved 2007-11-04. {{cite web}}: line feed character in |title= at position 42 (help)
  38. ^ Senghas R, Dolan M (1997). "Induced abortion and the risk of breast cancer". N Engl J Med. 336 (25): 1834, author reply 1835. PMID 9190497.
  39. Reeves G, Kan S, Key T, Tjønneland A, Olsen A, Overvad K, Peeters P, Clavel-Chapelon F, Paoletti X, Berrino F, Krogh V, Palli D, Tumino R, Panico S, Vineis P, Gonzalez C, Ardanaz E, Martinez C, Amiano P, Quiros J, Tormo M, Khaw K, Trichopoulou A, Psaltopoulou T, Kalapothaki V, Nagel G, Chang-Claude J, Boeing H, Lahmann P, Wirfält E, Kaaks R, Riboli E (2006). "Breast cancer risk in relation to abortion: Results from the EPIC study". Int. J. Cancer. 119 (7): 1741–5. PMID 16646050.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  40. Rosenblatt K, Gao D, Ray R, Rowland M, Nelson Z, Wernli K, Li W, Thomas D (2006). "Induced abortions and the risk of all cancers combined and site-specific cancers in Shanghai". Cancer Causes Control. 17 (10): 1275–80. PMID 17111259.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  41. Harris BM, Eklund G, Meirik O, Rutqvist LE, Wiklund K (1989). "Risk of cancer of the breast after legal abortion during first trimester: a Swedish register study". BMJ. 299 (6713): 1430–2. PMID 2514825.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  42. ^ Cite error: The named reference BERAL was invoked but never defined (see the help page).
  43. "Breast Cancer Prevention Institute Fact Sheets". Retrieved 2007-11-04.
  44. ^ Meirik O, Adami HO, Eklund G (1998). "Relation between induced abortion and breast cancer". Journal of epidemiology and community health. 52 (3): 209–11. PMID 9616432.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  45. ^ Brind J, Chinchilli VM, Severs WB, Summy-Long J (1996). "Induced abortion as an independent risk factor for breast cancer: a comprehensive review and meta-analysis". Journal of epidemiology and community health. 50 (5): 481–96. PMID 8944853.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  46. "The Care of Women Requesting Induced Abortion" (PDF). Royal College of Obstetricians and Gynaecologists. Retrieved 2007-11-07.
  47. "Is there a link between abortion and breast cancer? A balanced review". religioustolerance.org. Retrieved 2007-11-04.
  48. ^ Daling JR, Malone KE, Voigt LF, White E, Weiss NS (1994). "Risk of breast cancer among young women: relationship to induced abortion". J. Natl. Cancer Inst. 86 (21): 1584–92. PMID 7932822.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  49. Daling JR, Brinton LA, Voigt LF; et al. (1996). "Risk of breast cancer among white women following induced abortion". Am. J. Epidemiol. 144 (4): 373–80. PMID 8712194. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  50. ^ Rookus MA, van Leeuwen FE (1996). "Induced abortion and risk for breast cancer: reporting (recall) bias in a Dutch case-control study". J. Natl. Cancer Inst. 88 (23): 1759–64. PMID 8944006.
  51. Sanderson M, Shu XO, Jin F; et al. (2001). "Abortion history and breast cancer risk: results from the Shanghai Breast Cancer Study". Int. J. Cancer. 92 (6): 899–905. doi:10.1002/ijc.1263. PMID 11351314. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  52. "Re: Health Magazine". catholiccitizens.org. Retrieved 2007-11-04.
  53. Brind J, Chinchilli VM (2004). "Breast cancer and induced abortions in China". Br. J. Cancer. 90 (11): 2244–5, author reply 2245–6. doi:10.1038/sj.bjc.6601853. PMID 15150586.
  54. Bartholomew LL, Grimes DA (1998). "The alleged association between induced abortion and risk of breast cancer: biology or bias?". Obstetrical & gynecological survey. 53 (11): 708–14. PMID 9812330.
  55. "Abortion and Breast Cancer: The Scientific Debate That Never Happened". catholiccitizens.org. Retrieved 2007-11-04.
  56. Weed DL, Kramer BS (1996). "Induced abortion, bias, and breast cancer: why epidemiology hasn't reached its limit". J. Natl. Cancer Inst. 88 (23): 1698–700. PMID 8943995.
  57. Lindefors-Harris BM, Eklund G, Adami HO, Meirik O (1991). "Response bias in a case-control study: analysis utilizing comparative data concerning legal abortions from two independent Swedish studies". Am. J. Epidemiol. 134 (9): 1003–8. PMID 1951288.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  58. Meirik O, Lund E, Adami HO, Bergström R, Christoffersen T, Bergsjö P (1986). "Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway". Lancet. 2 (8508): 650–4. PMID 2876135.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  59. Brind J, Chinchilli VM, Severs WB, Summy-Long J (1997). "Re: Induced abortion and risk for breast cancer: reporting (recall) bias in a Dutch case-control study". J. Natl. Cancer Inst. 89 (8): 588–90. PMID 9106653.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  60. Brewster DH, Stockton DL, Dobbie R, Bull D, Beral V (2005). "Risk of breast cancer after miscarriage or induced abortion: a Scottish record linkage case-control study". Journal of epidemiology and community health. 59 (4): 283–7. doi:10.1136/jech.2004.026393. PMID 15767381.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  61. Paoletti X, Clavel-Chapelon F (2003). "Induced and spontaneous abortion and breast cancer risk: results from the E3N cohort study". Int. J. Cancer. 106 (2): 270–6. doi:10.1002/ijc.11203. PMID 12800205.
  62. "The Recurrent Miscarriage Clinic - What Causes Recurrent Miscarriage?". st-marys.nhs.uk. Retrieved 2007-11-04.
  63. Kunz J, Keller PJ (1976). "HCG, HPL, oestradiol, progesterone and AFP in serum in patients with threatened abortion". British journal of obstetrics and gynaecology. 83 (8): 640–4. PMID 60125.
  64. "The Last Abortion Clinic". PBS.org. Retrieved 2007-11-04.
  65. "Group angered by billboards linking breast cancer to abortion". cbc.ca. Retrieved 2007-11-04.
  66. "Vote for the Golden Boob!". goldenboob.org. Retrieved 2007-11-04.
  67. ^ "ARCHIVE". crlp.org. Retrieved 2007-11-04. {{cite web}}: Text "3/28/02 - Judge Rejects Abortion-Breast Cancer Scare Tactic" ignored (help)
  68. "Physicians For Life - Abstinence, Abortion, Birth Control - Need to Inform Patients of Abortion - Breast Cancer Link". physiciansforlife.org. Retrieved 2007-11-04.
  69. ^ "John A. Kindley Law Office: The ABC Link". John Kindley. Retrieved 2007-11-07.
  70. "Weldon Letter". abortionbreastcancer.com. Retrieved 2007-11-04.
  71. "Questions on states' abortion warnings". The Boston Globe. Retrieved 2007-11-04.
  72. Chavkin W (1996). "Topics for our times: public health on the line--abortion and beyond". American journal of public health. 86 (9): 1204–6. PMID 8806368.
  73. "Medical Informed Consent". piercelaw.edu. Retrieved 2007-11-04.
  74. "Abortion Clinic of Fargo". redriverwomensclinic.com. Retrieved 2007-11-04.
  75. "Is there a link between abortion and breast cancer? A balanced review". religioustolerance.org. Retrieved 2007-11-04.
  76. "Beyond Mainstream - alternative news, progressive politics, holistic healing, humor jokes, alternative media, alternative culture". Retrieved 2007-10-20.
  77. "Judge rules in favor of abortion clinic". WorldNetDaily.com. Retrieved 2007-11-04.
  78. "Center for Reproductive Rights". crlp.org. Retrieved 2007-11-04.
  79. "Controversy over alleged breast cancer link lands abortion clinic in court". womenspress.com. Retrieved 2007-11-04.
  80. "CHAPTER 51-12 FALSE ADVERTISING" (PDF). legis.nd.gov. Retrieved 2007-11-04.
  81. "Amy Jo Kjolsrud v. MKB Management Corporation". Retrieved 2007-11-04.
  82. The Breast Cancer Epidemic: Modeling and Forecasts Based on Abortion and Other Risk Factors, by Patrick Carroll, MA. Published in the Journal of American Physicians and Surgeons, Fall 2007. Accessed November 15 2007.
  83. 2003 Resolution - Affirming the Sanctity of Human Life. A position statement from the Association of American Physicians and Surgeons, publisher of the Journal of American Physicians and Surgeons. Accessed November 15 2007.
  84. British women's right to choose is under covert attack, by Libby Brooks. Published in The Guardian on October 12 2007; accessed November 19 2007.

External links

Scientific

Pro-choice

Pro-life

Category: